Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 August 2023

Sporadic disruptions of academic activities occurred yesterday and this morning on the Bloemfontein, South and Qwaqwa Campuses.

In recent weeks, the university management has made various attempts to keep the campuses open for face-to-face learning and teaching amid challenges experienced with the disbursement of students’ National Student Financial Aid Scheme (NSFAS) allowances through eZaga, an online digital banking service, tasked with dispersing direct payments to NSFAS beneficiaries.

These attempts include, but are not limited to, the attendance of meetings by UFS representatives with NSFAS, arranged by Universities South Africa (USAf); meetings with NSFAS attended by Prof Francis Petersen, Vice-Chancellor and Principal; constant engagements with NSFAS by the university’s Financial Aid Office; a meeting with the Minister of Higher Education, Science and Innovation, Dr Blade Nzimande, to discuss the matter – this was postponed to a later date; constant engagements with the Institutional Student Representative Council (ISRC) on matters relating to NSFAS, etc. These attempts are, however, not acceptable to our students.

To minimise the risk to the academic programme, as well as the fact that this is a sector-wide challenge, the academic programme, (activities, classes, and assignments) will continue online as far as possible from 2 to 4 August 2023. Further information about students’ online academic programme will be communicated by the respective faculties.

The university management would like to thank our academic staff for their commitment during this time, and for ensuring that the academic programme continues through online delivery.

The university is not closed; all other activities will continue as normal.  All campuses are also accessible. The situation on the campuses is being monitored closely and the necessary security measures are in place to ensure the safety of students and staff.

The university’s protocol during protests provides guidance to students and staff on how to act during protests.

Students and staff will be updated on the situation.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept